MIT's Kornbluth Warns Frozen Federal Funds Threaten 30,000-Company Innovation Pipeline
Updated
Updated · MIT News · Jul 1
MIT's Kornbluth Warns Frozen Federal Funds Threaten 30,000-Company Innovation Pipeline
1 articles · Updated · MIT News · Jul 1
Summary
Sally Kornbluth said federal money already appropriated to universities has largely not been released, putting curiosity-driven research and the U.S. talent pipeline at risk.
At a Washington Post Live panel with ASU President Michael Crow, she argued breakthroughs often emerge only after 30, 40 or 50 years of basic science without immediate commercial return.
Kornbluth tied that case to medicine, citing diabetes research moving from insulin injections to pumps, CGMs and a potential stem-cell cure, while saying immunotherapy is still expanding beyond some cancers.
She also said MIT is reshaping education for an AI-enabled world by emphasizing foundational STEM, writing, teamwork and ethical training so students use AI as an augmentation tool rather than a substitute for collaboration.
To show the broader stakes, Kornbluth said MIT has spun out more than 30,000 companies, that 20% of its class of 2029 are first-generation students, and that free tuition reaches families earning under $200,000.
As universities admit fewer science graduate students, who will power America's future innovation and national security?
If curiosity-driven research loses funding, where will the next unexpected life-saving cures and technologies come from?
With US labs shrinking from funding cuts, are we ceding future scientific breakthroughs to global competitors?
MIT Under Strain: How Federal Funding Cuts and Policy Shifts Threaten America's Innovation Pipeline and Scientific Workforce
Overview
MIT is facing serious challenges in 2025-2026, with a clear decline in research output and growing difficulty in securing research funding. This situation began with a hike in the endowment tax under President Trump, which triggered a cascade of funding cuts at MIT. At the same time, major federal agencies like the NSF and NIH saw significant budget reductions, causing widespread impacts on top institutions such as MIT and Harvard. Although Congress later restored much of the funding, MIT still struggles to maintain its previous research activity, highlighting a critical threat to both innovation and the future scientific workforce.